These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1745841)
1. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo. Olivieri D; Ciaccia A; Marangio E; Marsico S; Todisco T; Del Vita M Respiration; 1991; 58(3-4):117-21. PubMed ID: 1745841 [TBL] [Abstract][Full Text] [Related]
2. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial. Valenti S; Marenco G Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235 [TBL] [Abstract][Full Text] [Related]
8. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. Chalmers JD; Haworth CS; Metersky ML; Loebinger MR; Blasi F; Sibila O; O'Donnell AE; Sullivan EJ; Mange KC; Fernandez C; Zou J; Daley CL; N Engl J Med; 2020 Nov; 383(22):2127-2137. PubMed ID: 32897034 [TBL] [Abstract][Full Text] [Related]
9. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996 [TBL] [Abstract][Full Text] [Related]
13. Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial. Herrero-Cortina B; Alcaraz V; Vilaró J; Torres A; Polverino E J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):281-289. PubMed ID: 29878856 [TBL] [Abstract][Full Text] [Related]
14. A controlled trial of bromhexine ('Bisolvon') in out-patients with chronic bronchitis. Lal S; Bhalla KK Curr Med Res Opin; 1975; 3(2):63-7. PubMed ID: 1095307 [TBL] [Abstract][Full Text] [Related]
15. Inhaled steroids in patients with bronchiectasis. Elborn JS; Johnston B; Allen F; Clarke J; McGarry J; Varghese G Respir Med; 1992 Mar; 86(2):121-4. PubMed ID: 1615177 [TBL] [Abstract][Full Text] [Related]
16. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions. Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084 [TBL] [Abstract][Full Text] [Related]
17. Effect of H1- and H2-receptor antagonists on sputum volume and lung function in patients with generalized bronchiectasis. Anderson J; Eiser NM; Mills JG Br J Dis Chest; 1985 Jul; 79(3):272-4. PubMed ID: 2861844 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of low-dose erythromycin in bronchiectasis. Tsang KW; Ho PI; Chan KN; Ip MS; Lam WK; Ho CS; Yuen KY; Ooi GC; Amitani R; Tanaka E Eur Respir J; 1999 Feb; 13(2):361-4. PubMed ID: 10065682 [TBL] [Abstract][Full Text] [Related]
19. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815 [TBL] [Abstract][Full Text] [Related]
20. Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections. Taskar VS; Sharma RR; Goswami R; John PJ; Mahashur AA Respir Med; 1992 Mar; 86(2):157-60. PubMed ID: 1615182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]